| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.86 Billion | USD 13.86 Billion | 9% | 2024 |
FrequentlyAsked Questions
The Global eubiotics market is expected to grow due to ban on antibiotic growth promoters, rising demand for gut health in livestock, and growing awareness of animal welfare.
According to a study, the Global eubiotics market size was worth around USD 5.86 Billion in 2024 and is expected to reach USD 13.86 Billion by 2034.
The Global eubiotics market is expected to grow at a CAGR of 9% during the forecast period.
North America is expected to dominate the eubiotics market over the forecast period.
Leading players in the Global eubiotics market include DSM, Novozymes, Kemin Industries, Inc., Roquette Frères, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS, Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill, Incorporated, BASF SE, Chr. Hansen Holding A/S, and ADDCON GmbH among other Global players., among others.
The report explores crucial aspects of the eubiotics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients